Mary V. Relling
Mary V. Relling
Mary V. Relling is a renowned American pharmacologist known for her significant contributions to the field of pharmacogenomics. She has made substantial advancements in understanding how genetic variations influence an individual's response to medications, particularly in the treatment of childhood leukemia.
Early Life and Education[edit | edit source]
Mary V. Relling was born in the United States and developed a passion for pharmacology early in her life. She pursued her higher education at UCSF, where she obtained her degree in pharmacology.
Career[edit | edit source]
Relling's career in pharmacogenomics began at the St. Jude Children's Research Hospital in Memphis, Tennessee. She focused her research on identifying genetic markers that could predict how patients would respond to chemotherapy drugs used in leukemia treatment. Her groundbreaking work has led to more personalized and effective treatment strategies for pediatric cancer patients.
Research Contributions[edit | edit source]
Relling's research has significantly advanced the field of pharmacogenomics by demonstrating the importance of genetic factors in drug response. Her studies have paved the way for precision medicine approaches in cancer treatment, improving outcomes and reducing adverse effects for patients.
Awards and Recognition[edit | edit source]
Throughout her career, Mary V. Relling has received numerous awards and honors for her pioneering work in pharmacogenomics. Her research has been widely recognized for its impact on improving patient care and treatment outcomes.
Legacy[edit | edit source]
Mary V. Relling's contributions to pharmacogenomics have had a lasting impact on the field of medicine, particularly in the treatment of childhood leukemia. Her research continues to inspire future generations of scientists and clinicians to explore the role of genetics in drug response and personalized medicine.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
